Literature DB >> 11856242

Bacteroides species highly resistant to metronidazole: an emerging clinical problem?

V.O. Rotimi1, M. Khoursheed, J.S. Brazier, W.Y. Jamal, F.B. Khodakhast.   

Abstract

Entities:  

Year:  1999        PMID： 11856242     DOI： 10.1111/j.1469-0691.1999.tb00531.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  12 in total

1.  Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates.

Authors:  Sonja Löfmark; Hong Fang; Maria Hedberg; Charlotta Edlund
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Authors:  Carmen Betriu; Esther Culebras; María Gómez; Fátima López; Iciar Rodríguez-Avial; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

3.  Bacteremia caused by a metronidazole-resistant Prevotella sp. strain.

Authors:  Francine Mory; Jean-Philippe Carlier; Corentine Alauzet; Maxime Thouvenin; Hélène Schuhmacher; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.

Authors:  Kenneth E Aldridge; Megan O'Brien
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 5.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

6.  Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.

Authors:  K E Aldridge; D Ashcraft; K Cambre; C L Pierson; S G Jenkins; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Accumulation of norfloxacin by Bacteroides fragilis.

Authors:  V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes.

Authors:  S L Stubbs; J S Brazier; P R Talbot; B I Duerden
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

9.  Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.

Authors:  Kenneth E Aldridge; Deborah Ashcraft; Megan O'Brien; Charles V Sanders
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.

Authors:  Lee-Jene Teng; Po-Ren Hsueh; Jui-Chang Tsai; Shwu-Jen Liaw; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.